Physician profile
Tod C Engelhardt
NPI 1568462265
$6,933.85
in general payments reported to CMS, 2019-2025
14 companies · $534 in 2025
The $534 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $196 · 2021: $820 · 2022: $1,707 · 2023: $1,637 · 2024: $1,667 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,003 · Consulting Fee: $500 · Travel and Lodging: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,003.08 |
| Consulting Fee | $500.00 |
| Travel and Lodging | $334.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $2,047.66 | 2023-2025 | Symphony Catheter, Prodigy Catheter, Zoom 88-T Large Distal Platform |
| Inari Medical, INC. | $2,047.15 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Truvic Medical, INC. | $1,147.62 | 2022 | |
| W. L. Gore & Associates, INC. | $605.36 | 2023-2024 | Gore Tag Thoracic Endoprosthesis, Gore Cardioform Septal Occluder |
| Edwards Lifesciences Corporation | $517.54 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $145.52 | 2024-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Philips North America LLC | $113.88 | 2019-2024 | (Az7) Lasers |
| Angiodynamics, INC. | $107.05 | 2024 | Alphavac |
| Kestra Medical Technology Services, INC. | $65.56 | 2022-2025 | Assure Wcd |
| Medtronic Vascular, INC. | $37.18 | 2020 | |
| Janssen Pharmaceuticals, INC | $29.83 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $25.87 | 2025 | Opsynvi |
| Medtronic, INC. | $23.29 | 2023 | Venaseal |
| Terumo Medical Corporation | $20.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tod Engelhardt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.